Life Science VC Firm 5AM Ventures Raising $240 Million for New Fund

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

Life science venture investor 5AM Ventures disclosed in a regulatory filing on Thursday that it is raising $240 million for a new fund. The Menlo Park firm founded by Andrew Schwab focuses on seed and early stage investments. Its portfolio includes Burlingame-based Biodesy, a company with a protein function analysis tool that raised $15 million on Thursday and named Greg Yap as its CEO.

Help employers find you! Check out all the jobs and post your resume.

Back to news